Summit Financial Strategies’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$562K Hold
1,551
0.04% 94
2026
Q1
$546K Hold
1,551
0.04% 93
2025
Q4
$508K Buy
1,551
+71
+5% +$22.5K 0.04% 89
2025
Q3
$418K Hold
1,480
0.04% 104
2025
Q2
$413K Hold
1,480
0.04% 98
2025
Q1
$461K Buy
1,480
+80
+6% +$23.6K 0.05% 89
2024
Q4
$365K Hold
1,400
0.04% 100
2024
Q3
$451K Hold
1,400
0.05% 90
2024
Q2
$437K Hold
1,400
0.05% 87
2024
Q1
$398K Hold
1,400
0.06% 93
2023
Q4
$403K Hold
1,400
0.06% 88
2023
Q3
$376K Sell
1,400
-115
-8% -$28.7K 0.07% 86
2023
Q2
$336K Buy
1,515
+115
+8% +$26.7K 0.06% 91
2023
Q1
$338K Hold
1,400
0.07% 87
2022
Q4
$368K Hold
1,400
0.08% 80
2022
Q3
$316K Hold
1,400
0.08% 86
2022
Q2
$341K Hold
1,400
0.08% 77
2022
Q1
$339K Hold
1,400
0.07% 80
2021
Q4
$315K Hold
1,400
0.06% 89
2021
Q3
$298K Hold
1,400
0.06% 91
2021
Q2
$341K Hold
1,400
0.07% 82
2021
Q1
$348K Sell
1,400
-35
-2% -$8.35K 0.12% 48
2020
Q4
$330K Buy
1,435
+35
+3% +$8.07K 0.11% 59
2020
Q3
$356K Hold
1,400
0.15% 47
2020
Q2
$330K Hold
1,400
0.15% 49
2020
Q1
$284K Sell
1,400
-30
-2% -$6.55K 0.15% 43
2019
Q4
$345K Buy
+1,430
New +$315K 0.17% 41

Other funds holding AMGN

Summit Financial Strategies's AMGN Position: Q2 2026 in Review

Summit Financial Strategies held its Amgen (AMGN) position steady in Q2 2026 at 1,551 shares worth $562K. The position accounts for 0.04% of the portfolio, ranked #94.

Summit Financial Strategies first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Summit Financial Strategies held 1,551 shares of Amgen worth $562K as of Q2 2026.
  • Summit Financial Strategies left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.04% of Summit Financial Strategies's portfolio in Q2 2026, its #94 holding.
  • Summit Financial Strategies first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Summit Financial Strategies's 13F filing for Q2 2026, filed 24 Jul 2026.